Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aripiprazole (substance) |
Is a |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dihydrocarbostyril derivative antipsychotic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aripiprazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aripiprazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aripiprazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aripiprazole 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aripiprazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aripiprazole 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dihydrocarbostyril derivative antipsychotic agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|